Voyager Therapeutics VYGR
NASDAQ VYGR
$2.68 +0.04 (+1.52%)
As of: Sep 30, 2026 · 3:11 PM EDT

Voyager Therapeutics (VYGR) Common Equity (2014 - 2026)

Updated

Voyager Therapeutics (VYGR) recorded Common Equity of $154.38 million in Q2 2026, down 36.7% from $243.94 million a year earlier and down 11.1% from the prior quarter.

Analysis

Voyager Therapeutics (VYGR) Common Equity (2014 - 2026) Analysis & Trends

At the end of FY2025, Voyager Therapeutics reported Common Equity of $196.08 million, down 34.6% from FY2024.

  • Annual Common Equity has a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
  • Across earlier years, Common Equity came in at $299.76 million in FY2024 (+26.8%), $236.32 million in FY2023 (+300.4%), $59.02 million in FY2022 (-37.9%) and $95.06 million in FY2021 (-38.4%).
  • The Q2 2026 figure is the lowest quarterly Common Equity since Q4 2022.
  • On a year-over-year basis, Common Equity has declined for six consecutive quarters, with an average decline of 9.3% over the last eight quarters.
  • Peak year-over-year performance for Common Equity in the last five years was growth of 300.4% in Q4 2023, against a decline of 47.4% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $173.67 million (Q1 2026), $196.08 million (Q4 2025) and $219.83 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 84.97 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -5.94 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 50.37 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 20.25 Bn
10 Voyager Therapeutics 161.76 Mn -501.43 Mn - 154.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 154.38 Mn
Mar 31, 2026 173.67 Mn
Dec 31, 2025 196.08 Mn
Sep 30, 2025 219.83 Mn
Jun 30, 2025 243.94 Mn
Mar 31, 2025 272.70 Mn
Dec 31, 2024 299.76 Mn
Sep 30, 2024 330.31 Mn
Jun 30, 2024 335.42 Mn
Mar 31, 2024 340.89 Mn
Dec 31, 2023 236.32 Mn
Sep 30, 2023 176.22 Mn
Jun 30, 2023 199.03 Mn
Mar 31, 2023 216.96 Mn
Dec 31, 2022 59.02 Mn
Sep 30, 2022 79.82 Mn
Jun 30, 2022 60.05 Mn
Mar 31, 2022 75.93 Mn
Dec 31, 2021 95.06 Mn
Sep 30, 2021 87.42 Mn
API Access

Voyager Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=VYGR&period=max&api_key=YOUR_API_KEY